{
  "thread": {
    "uuid": "172f5fe4732592400fe9cb78b7f602d48d408b2f",
    "url": "https://cj.sina.cn/article/norm_detail?url=https://finance.sina.com.cn/money/fund/aiassistant/zcgyd/2026-01-15/doc-inhhkmpv3313117.shtml&vt=4",
    "site_full": "cj.sina.cn",
    "site": "sina.cn",
    "site_section": "https://finance.sina.cn/?from=redirect",
    "site_categories": [
      "top_news_hk",
      "top_news_my",
      "top_news_sg",
      "top_news_tw",
      "top_news",
      "politics",
      "science and technology",
      "economy, business and finance"
    ],
    "section_title": "新浪财经_金融信息服务商",
    "site_title": "财经头条_新浪财经_金融信息服务商",
    "title": "益方生物股价跌5.1%，上银基金旗下1只基金重仓，持有33.81万股浮亏损失54.77万元",
    "title_full": "益方生物股价跌5.1%，上银基金旗下1只基金重仓，持有33.81万股浮亏损失54.77万元",
    "published": "2026-01-15T07:59:00.000+02:00",
    "replies_count": 0,
    "participants_count": 0,
    "site_type": "news",
    "country": "CN",
    "main_image": "https://n.sinaimg.cn/finance/c30320b4/20210712/wx_poster_finance1.png",
    "performance_score": 0,
    "domain_rank": 4801,
    "domain_rank_updated": "2026-01-11T23:00:00.000+02:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "172f5fe4732592400fe9cb78b7f602d48d408b2f",
  "url": "https://cj.sina.cn/article/norm_detail?url=https://finance.sina.com.cn/money/fund/aiassistant/zcgyd/2026-01-15/doc-inhhkmpv3313117.shtml&vt=4",
  "ord_in_thread": 0,
  "author": null,
  "published": "2026-01-15T07:59:00.000+02:00",
  "title": "益方生物股价跌5.1%，上银基金旗下1只基金重仓，持有33.81万股浮亏损失54.77万元",
  "text": "1月15日， 益方生物 跌5.1%，截至发稿，报30.12元/股，成交3.36亿元，换手率2.60%，总市值174.20亿元。\n资料显示， 益方生物科技(上海)股份有限公司 位于中国(上海) 自由贸易 试验区李冰路67弄4号210室,香港湾仔皇后大道东183号合和中心46楼，成立日期2013年1月11日，上市日期2022年7月25日，公司主营业务涉及创新药物的研发、生产和销售。主营业务收入构成为：技术授权和技术合作收入100.00%。\n从基金十大 重仓股 角度\n数据显示，上银基金旗下1只 基金重仓 益方生物。 上银医疗健康混合A （011288）三季度减持3.76万股，持有股数33.81万股，占 基金净值 比例为4.16%，位居第八大重仓股。根据测算，今日浮亏损失约54.77万元。\n上银医疗健康混合A（011288）成立日期2021年3月30日，最新规模1.19亿。今年以来收益9.14%，同类排名1107/8840；近一年收益43.39%，同类排名2634/8094；成立以来亏损20.56%。\n上银医疗健康混合A（011288）基金经理为杨建楠。\n截至发稿，杨建楠累计任职时间3年326天，现任基金资产总规模2.53亿元，任职期间最佳基金回报6.26%， 任职期间最差基金回报4.48%。\n风险提示：市场有风险， 投资 需谨慎。本文为 AI 大模型 自动发布，任何在本文出现的信息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建议。\nMACD金叉信号形成，这些股涨势不错！\n打开App看更多精彩内容",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "chinese",
  "sentiment": "negative",
  "categories": [
    "Economy, Business and Finance"
  ],
  "topics": [
    "Economy, Business and Finance->investment and opinion pieces",
    "Economy, Business and Finance->financial service",
    "Economy, Business and Finance->market and exchange"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": true,
  "webz_reporter": false,
  "external_links": [],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": []
  },
  "syndication": {
    "syndicated": null,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [
      "top_news_hk",
      "top_news_my",
      "top_news_sg",
      "top_news_tw",
      "top_news"
    ],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2026-01-15T08:05:13.683+02:00",
  "updated": "2026-01-15T08:11:27.000+02:00"
}